FDA Warning Letter — Rocky Mountain Apothecary DBA Rocky Mountain Pharmacy

Case 574231 — FEI 3013935808

The FDA took a Warning Letter action against Rocky Mountain Apothecary DBA Rocky Mountain Pharmacy on May 14, 2019 (Bozeman, MT). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Rocky Mountain Apothecary DBA Rocky Mountain Pharmacy
Date
May 14, 2019
Fiscal Year
2019
Product Type
Drugs
Center
CDER
Location
Bozeman, MT (United States)